Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa E M Hopcroft

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Journal of Molecular Biology|November 11, 2009
Compensated pathogenic deviations: analysis of structural effectsAnja Baresić, Lisa E M Hopcroft, Hubert H Rogers, et al.
BMC Bioinformatics|October 14, 2011
Characterization of pathogenic germline mutations in human protein kinasesJose M G Izarzugaza, Lisa E M Hopcroft, Anja Baresic, et al.
Cancers|November 11, 2022
Tyrosine Kinase Inhibitor Independent Gene Expression Signature in CML Offers New Targets for LSPC Eradication TherapyEduardo Gómez-Castañeda, Lisa E M Hopcroft, Simon Rogers, et al.
Blood|October 30, 2016
CML cells actively evade host immune surveillance through cytokine-mediated downregulation of MHC-II expressionAnuradha Tarafdar, Lisa E M Hopcroft, Paolo Gallipoli, et al.
Nucleic Acids Research|June 24, 2010
Predictive response-relevant clustering of expression data provides insights into disease processesLisa E M Hopcroft, Martin W McBride, Keith J Harris, et al.
Stem Cells (Dayton, Ohio)|May 9, 2014
The antiproliferative activity of kinase inhibitors in chronic myeloid leukemia cells is mediated by FOXO transcription factorsFrancesca Pellicano, Mary T Scott, G Vignir Helgason, et al.
JMIR Medical Informatics|December 20, 2022
Identifying Patterns of Clinical Interest in Clinicians' Treatment Preferences: Hypothesis-free Data Science Approach to Prioritizing Prescribing Outliers for Clinical ReviewBrian MacKenna, Helen J Curtis, Lisa E M Hopcroft, et al.
Cancer Discovery|September 16, 2016
Epigenetic Reprogramming Sensitizes CML Stem Cells to Combined EZH2 and Tyrosine Kinase InhibitionMary T Scott, Koorosh Korfi, Peter Saffrey, et al.
Blood|May 26, 2016
CXCR2 and CXCL4 regulate survival and self-renewal of hematopoietic stem/progenitor cellsAmy Sinclair, Laura Park, Mansi Shah, et al.
International Journal of Epidemiology|January 3, 2022
Cohort Profile: The COVID-19 in Pregnancy in Scotland (COPS) dynamic cohort of pregnant women to assess effects of viral and vaccine exposures on pregnancySarah J Stock, Jade Carruthers, Cheryl Denny, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Journal of Molecular Biology|November 11, 2009
Compensated pathogenic deviations: analysis of structural effectsAnja Baresić, Lisa E M Hopcroft, Hubert H Rogers, et al.
BMC Bioinformatics|October 14, 2011
Characterization of pathogenic germline mutations in human protein kinasesJose M G Izarzugaza, Lisa E M Hopcroft, Anja Baresic, et al.
Cancers|November 11, 2022
Tyrosine Kinase Inhibitor Independent Gene Expression Signature in CML Offers New Targets for LSPC Eradication TherapyEduardo Gómez-Castañeda, Lisa E M Hopcroft, Simon Rogers, et al.
Blood|October 30, 2016
CML cells actively evade host immune surveillance through cytokine-mediated downregulation of MHC-II expressionAnuradha Tarafdar, Lisa E M Hopcroft, Paolo Gallipoli, et al.
Nucleic Acids Research|June 24, 2010
Predictive response-relevant clustering of expression data provides insights into disease processesLisa E M Hopcroft, Martin W McBride, Keith J Harris, et al.
Stem Cells (Dayton, Ohio)|May 9, 2014
The antiproliferative activity of kinase inhibitors in chronic myeloid leukemia cells is mediated by FOXO transcription factorsFrancesca Pellicano, Mary T Scott, G Vignir Helgason, et al.
JMIR Medical Informatics|December 20, 2022
Identifying Patterns of Clinical Interest in Clinicians' Treatment Preferences: Hypothesis-free Data Science Approach to Prioritizing Prescribing Outliers for Clinical ReviewBrian MacKenna, Helen J Curtis, Lisa E M Hopcroft, et al.
Cancer Discovery|September 16, 2016
Epigenetic Reprogramming Sensitizes CML Stem Cells to Combined EZH2 and Tyrosine Kinase InhibitionMary T Scott, Koorosh Korfi, Peter Saffrey, et al.
Blood|May 26, 2016
CXCR2 and CXCL4 regulate survival and self-renewal of hematopoietic stem/progenitor cellsAmy Sinclair, Laura Park, Mansi Shah, et al.
International Journal of Epidemiology|January 3, 2022
Cohort Profile: The COVID-19 in Pregnancy in Scotland (COPS) dynamic cohort of pregnant women to assess effects of viral and vaccine exposures on pregnancySarah J Stock, Jade Carruthers, Cheryl Denny, et al.
Pageof 3